| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 13 Nov 2025 | 7 Nov 2025 |
| Yatharth Hospital & Trauma Care Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2025 inter alia to consider and approve the Unaudited Financial Results (Standalone & Consolidated) of the Company for the second quarter and half year ended September 30 2025. We hereby submit Outcome of the Board Meeting of the Company held on today. i.e. November 13, 2025. (As per BSE Announcement dated on: 13.11.2025) | ||
| Board Meeting | 5 Aug 2025 | 31 Jul 2025 |
| Yatharth Hospital & Trauma Care Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2025 inter alia to consider and approve Unaudited Financial Results for the first quarter ended June 30 2025. We hereby submit Outcome of the Board Meeting (As per BSE Announcement Dated on 05/08/2025) | ||
| Board Meeting | 17 Jul 2025 | 17 Jul 2025 |
| We hereby inform that the Company has shifted its Corporate Office | ||
| Board Meeting | 26 May 2025 | 19 May 2025 |
| Yatharth Hospital & Trauma Care Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2025 inter alia to consider and approve We hereby submit intimation of the Board Meeting is scheduled to be held on Monday May 26 2025. We hereby submit Audited Financial Results for the Q4 & FY25 (As Per BSE Announcement Dated on 26.05.2025) | ||
| Board Meeting | 27 Jan 2025 | 21 Jan 2025 |
| Yatharth Hospital & Trauma Care Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/01/2025 inter alia to consider and approve To consider and approve the financial results of the company for the quarter ended December 31 2024. Quarterly Financial Result for Q3FY25 (As Per BSE Announcement Dated on: 27/01/2025) | ||
The hospital chain’s EBITDA for the March 2025 quarter jumped 22.7 YoY% to ₹57.2 crore against ₹46.6 crore in Q4 FY24
The QIP shares were at ₹595 per share which was 5% lower compared with the floor price of ₹626.
The strategic purchase intends to increase Yatharth Hospital's presence in the Delhi-NCR region, hence increasing its regional footprint.
This strategic acquisition is intended to strengthen Yatharth Hospital's presence in the Delhi-NCR region and expand its reach to serve a larger population.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.